MY ACCOUNT | NEWSLETTER |

Cutaneous epitheliotropic T-cell lymphoma in ferrets


Tumors are commonly encountered in ferrets and lymphoma is the third most common neoplasm in this species. Cutaneous epitheliotropic lymphoma has rarely been described in ferrets.

Inclusion criteria for ferrets in this study were cutaneous lymphoma diagnosed by histopathologic examination. Data collection from affected ferrets presented at the clinic between January 2014 and March 2021 included signalment, medical history, clinical signs, histopathology and immunohistochemistry results, treatments and clinical outcome when available.

Three ferrets met the inclusion criteria. They presented with erythematous and crusted lesions on the foot in ferrets 1 and 2, and multiple erythematous papules over the lumbar region in ferret 3. Epitheliotropic T-cell lymphoma was identified by immunohistochemistry in all cases. 

Chemotherapy was declined by the owners of ferret 1 and a medical treatment based on prednisolone, a skin ointment and spirulina was initiated. Ferret 2 received lomustine and prednisolone. Ferret 3 received chlorambucil, an isotretinoin skin ointment and prednisolone. In all cases, dermatologic symptoms significantly improved or disappeared after one to three months. 

Ferret 1 was lost to follow up after two months. Ferret 2 discontinued chemotherapy after seven months and was humanely euthanized three months later after recurrence and worsening of its general condition. Ferret 3 died three months after diagnosis from an unknown cause.

The authors in this case series described three cases of cutaneous epitheliotropic T-cell lymphoma, with three different treatment plans. Researchers illustrated the importance of considering cutaneous epitheliotropic lymphoma as a differential diagnosis in ferrets with dermatologic symptoms.

Cécile Bernhard, et al. “Cutaneous epitheliotropic T-cell lymphoma in ferrets (Mustela putorius furo): 3 cases (2014-2021).” Journal of Exotic Pet Medicine, 3 November 2022. https://doi.org/10.1053/j.jepm.2022.10.006

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Advancing the 3Rs: innovation, implementation, ethics and society

Like0
Dislike0

Automated Knowledge-Based Radiation Treatment Planning in Canine and Feline Nasal Tumors

Like0
Dislike0

Does Lung Function Imaging Modality Have a Dosimetric Impact On Functional Avoidance Treatment Planning: Assessment Using Prospective Clinical Trial Data

Like0
Dislike0

One Committed and Caring NC State Veterinary Student, So Many Choices

Like0
Dislike0

Dentalis Earns 5 VOHC® Seals, Positioning for Global Expansion in Animal Health

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top